Mark C. Wiggins, EVP Corporate and Business Development at BIOGEN IDEC INC (BIIB), sold 43,737 shares at $47.59 ($2.1M) on 2007-04-23, disclosed to the SEC on 2007-04-25.
Scheduled sale ($2.1M) by EVP Corporate and Business Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ZGNX | BUY | 2020-03-24 | $51K | — | Filing → |
| TCON | BUY | 2020-01-24 | $20K | — | Filing → |
| ZGNX | SELL | 2019-08-12 | $313K | — | Filing → |